MLLCF vs AMGN: Which Stock is Better?

Side-by-side comparison of Molecular Partners AG and Amgen Inc in 2026

Comparison Updated:

MLLCF

Molecular Partners AG

$3.50

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricMLLCFAMGNWinner
Market Cap$132.00M$177.92BAMGN
P/E RatioN/A25.57AMGN
EPS (TTM)$N/A$12.92AMGN
Revenue Growth-1.0%0.1%AMGN
Gross Margin0.0%70.1%AMGN

Analyze MLLCF

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MLLCF or AMGN a better investment?

Comparing MLLCF and AMGN: Molecular Partners AG has a market cap of $132.00M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MLLCF and AMGN?

MLLCF (Molecular Partners AG) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MLLCF or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MLLCF or AMGN?

AMGN has higher revenue growth at 0.1% vs -1.0% for MLLCF.

Which company is more profitable: MLLCF or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 0.0% for MLLCF.

Which is the larger company: MLLCF or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $132.00M for MLLCF.

Should I buy MLLCF or AMGN in 2026?

Both MLLCF and AMGN have investment merit. MLLCF trades at $3.50 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MLLCF and AMGN stock?

Key differences: Market Cap ($132.00M vs $177.92B), P/E Ratio (N/A vs 25.6x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 70.1%).

Popular Stock Comparisons